ABG Analytics logo
Get updates

Celgene Corp (NASDAQ: CELG)

DRUGS - Biotechnology
Sector: Health Care
Stock price data as of 05/17/2019
Closing price: 95.42
Support price level: $92.84
Resistance price level: N/A
Relative strength index (14-day RSI) 55.7
Beta 1.48
  • CELG is at or near its 52-week high. Studies have found that such stocks have an increased probability of outperforming the market over the next year.

  • The price of this high-beta stock is expected to increase by 1.48% for every 1% increase in the S&P-500.

  • Volatility is forecast to fall over the next month.

  • Price broke above prior resistance level - a short-term bullish signal.

Low High Price as % of Range
$59.21 $96.88 96.9%
200 day 50 day 20 day 10 day
$84.92 $92.55 $94.87 $95.27
(Annualized standard deviation)
Historical
(5 year)
Last month Current estimate Next month forecast
31.4% 27.1% 24.5% 27.9%
There is an estimated 5% probability that the stock price of Celgene Corp will fall by more than:
  • 6.7% in the next week.

  • 15.8% in the next month.

  • 68.5% in the next year.